Literature DB >> 4830117

Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome.

H W Sutherland, P D Bewsher, J D Cormack, C R Hughes, A Reid, G Russell, J M Stowers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4830117      PMCID： PMC1648755          DOI： 10.1136/adc.49.4.283

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  16 in total

1.  Hypoglycaemia in the newborn. A sequel of intrauterine malnutrition.

Authors:  G A NELIGAN; E ROBSON; J WATSON
Journal:  Lancet       Date:  1963-06-15       Impact factor: 79.321

2.  A laboratory and clinical study of chlorpropamide in ambulatory diabetics.

Authors:  M B HANDELSMAN; L LEVITT; M F CALABRETTA
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

3.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.

Authors:  A S HUGGETT; D A NIXON
Journal:  Lancet       Date:  1957-08-24       Impact factor: 79.321

4.  Pathological changes in the nervous system in severe neonatal hypoglycaemia.

Authors:  J M Anderson; R D Milner; S J Strich
Journal:  Lancet       Date:  1966-08-13       Impact factor: 79.321

5.  Sulphonylurea therapy in the treatment of the pregnant diabetic.

Authors:  M Notelovitz
Journal:  S Afr Med J       Date:  1971-02-27

6.  The assessment of fetal growth.

Authors:  A M Thomson; W Z Billewicz; F E Hytten
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-09

7.  Prolonged symptomatic neonatal hypoglycemia associated with maternal chlorpropamide therapy.

Authors:  P Zucker; G Simon
Journal:  Pediatrics       Date:  1968-11       Impact factor: 7.124

8.  Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy.

Authors:  M L Kemball; C McIver; R D Milner; C H Nourse; D Schiff; J R Tiernan
Journal:  Arch Dis Child       Date:  1970-10       Impact factor: 3.791

9.  Use of chlorpropamide in the treatment of diabetes in pregnancy.

Authors:  C P Douglas; R Richards
Journal:  Diabetes       Date:  1967-01       Impact factor: 9.461

10.  Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy.

Authors:  H W Sutherland; J M Stowers; J D Cormack; P D Bewsher
Journal:  Br Med J       Date:  1973-07-07
View more
  8 in total

1.  Treatment of gestational diabetes: oral hypoglycemic agents or insulin?

Authors:  Marianna Faraci; Fosca A F Di Prima; Oriana Valenti; Entela Hyseni; Santo Monte; Elsa Giorgio; Roberta De Domenico
Journal:  J Prenat Med       Date:  2011-07

Review 2.  Management of the pregnant diabetic patient.

Authors:  H W Sutherland; D W Pearson; J K Powrie
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

3.  The influence of D-chiro-inositol and D-myo-inositol in pregnant women with glucose intolerance.

Authors:  Domenico Dell'Edera; Francesca Sarlo; Arianna Allegretti; Francesca Simone; Maria Giovanna Lupo; Annunziata Anna Epifania
Journal:  Biomed Rep       Date:  2017-07-04

Review 4.  Oral Hypoglycemic Agents in pregnancy: An Update.

Authors:  Nagandla Kavitha; Somsubhra De; Sachchithanantham Kanagasabai
Journal:  J Obstet Gynaecol India       Date:  2013-03-27

Review 5.  Using oral agents to manage gestational diabetes: what have we learned?

Authors:  Elizabeth Buschur; Florence Brown; Jennifer Wyckoff
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

6.  Chlorpropamide in pregnancy and transient neonatal diabetes insipidus.

Authors:  J D Uhrig; R M Hurley
Journal:  Can Med Assoc J       Date:  1983-02-15       Impact factor: 8.262

Review 7.  Maternal-fetal transport of hypoglycaemic drugs.

Authors:  Facundo Garcia-Bournissen; Denice S Feig; Gideon Koren
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 8.  Pharmacological Management of Gestational Diabetes Mellitus.

Authors:  Riki Bergel; Eran Hadar; Yoel Toledano; Moshe Hod
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.